ブリティッシュ・コロンビア州(B.C.)は、カナダで最も急速に成長している生命科学セクターを擁し、科学的なイノベーションが活況を呈しています。事実、同州を拠点とする生命科学企業数は、2018年から2021年までに26.5%増加しています。人材、パートナーシップ、インフラストラクチャーおよび投資に関する協力的で緊密なエコシステムが同セクターの特徴といえます。
B.C.は、50以上の生命科学研究センターと複数のセンター・オブ・エクセレンスの拠点に
BCの生命科学(2018〜2021年)B.C.では、カナダで生命科学のスタートアップ企業が最も急速に成長
生命科学セクター紹介(2023年5月)雇用成長の速度は全州のなかで第2位
生命科学セクター紹介(2023年5月)B.C. is a leading centre for scientific innovation and the sector demonstrates a particular strength in research and development (R&D). Overall, the R&D industry, a subset of the Research, Testing and Medical Laboratories industry group, made up over one-quarter (26%) of the sector’s total employment in 2021, the highest share in Canada.
As British Columbia’s prime location on Canada’s Pacific coast, immediately north of Washington State, provides a natural gateway to Asia as well as easy access to the United States. Collaboration across time zones is made possible by the fact that B.C.’s business day overlaps with morning work schedules in Asia, afternoon working hours in Europe, and is synchronized for the full day with California and Washington State.
Life Sciences businesses in British Columbia benefit from the province’s open and diversified economy, advantageous location, attractive investment climate and skilled workforce. With the B.C. Life Sciences and Biomanufacturing Strategy, the government is positioning B.C. as a global hub for life sciences and biomanufacturing and the development of commercial-scale biopharmaceutical and medical manufacturing. Canadian controlled businesses in B.C. may qualify for a scientific research and experimental development (SR&ED) tax credit top up of 10% if they qualify for the federal government SR&ED tax credit of up to 35%. In addition, the Small Business Venture Capital tax credit encourages investors to make equity capital investments in B.C. small businesses. This gives B.C. entrepreneurs access to early-stage venture capital to help them expand and develop their businesses.
At the forefront of innovation and research in the industry, B.C.’s 25 public post-secondary institutions offer a range of health sciences and applied and natural sciences training programs in areas such as biotechnology, microbiology and immunology, molecular biology, genetics, clinical genetics technology, behavioral neurosciences, and biomedical engineering and technology. The government is investing almost $75M over three years to create 3,000 more tech-learning spaces in the public post-secondary education system. These spaces cover a range of areas including life sciences. The B.C. Future Ready Action Plan will provide grants for new training opportunities, create more tech-relevant post-secondary spaces to meet demands, and address barriers to access education and skills training. In addition, the new National Biomanufacturing Training Centre located on the campus of the BC Institute of Technology, will offer hands-on biomanufacturing training to current and future industry employees.
B.C.’s life sciences sector is highly collaborative and supported by industry organizations and accelerators, governmental organizations, universities and research hospitals, and other organizations that co-ordinate and fund research and clinical trials. The new Clinical Support and Research Centre (CSRC) at the new St. Paul’s Hospital in Vancouver, will bring medical staff and researchers together – along with academic, industry researchers to explore new frontiers in bioengineering, nanotechnology, virtual reality, augmented reality and simulation. The partnerships forged in the province between researchers, academia, clinicians and industry, community organizations and government agencies facilitate the development, transfer and commercialization of knowledge.
当庁の貿易・投資担当者が、有意義な関係の構築、イベントや展示会への参加、プログラムやイニシアチブ検索などをお手伝いします。お近くの専門家にお問い合わせください。